Literature DB >> 36157097

Management of Massive Pulmonary Embolism.

Eva Polaková1, Josef Veselka1.   

Abstract

Pulmonary embolism is a potentially lethal manifestation of venous thromboembolic disease. It is one of the three main causes of cardiovascular morbidity and mortality in developed countries. Over the years, better diagnostic and risk stratification measures were implemented. A generous range of new treatment options is becoming available, particularly for management of massive pulmonary embolism. Nonetheless, clinicians often face uncertainty in clinical practice due to lack of scientific support for available treatment options. The aim of this article is to review management of massive pulmonary embolism. International College of Angiology. This article is published by Thieme.

Entities:  

Keywords:  ECMO; embolectomy; high-risk pulmonary embolism; massive pulmonary embolism; pulmonary embolism; reperfusion treatment; thrombolysis

Year:  2022        PMID: 36157097      PMCID: PMC9507601          DOI: 10.1055/s-0042-1756176

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  30 in total

1.  Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.

Authors:  Michael R Jaff; M Sean McMurtry; Stephen L Archer; Mary Cushman; Neil Goldenberg; Samuel Z Goldhaber; J Stephen Jenkins; Jeffrey A Kline; Andrew D Michaels; Patricia Thistlethwaite; Suresh Vedantham; R James White; Brenda K Zierler
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

2.  Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism.

Authors:  L B Daniels; J A Parker; S R Patel; F Grodstein; S Z Goldhaber
Journal:  Am J Cardiol       Date:  1997-07-15       Impact factor: 2.778

Review 3.  Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism.

Authors:  Kenneth E Wood
Journal:  Chest       Date:  2002-03       Impact factor: 9.410

4.  Is it Time to Sunset Ultrasound-Assisted Catheter-Directed Thrombolysis for Submassive PE?

Authors:  Akhilesh K Sista
Journal:  JACC Cardiovasc Interv       Date:  2021-06-28       Impact factor: 11.195

5.  Surgical Embolectomy for Acute Massive and Submassive Pulmonary Embolism in a Series of 115 Patients.

Authors:  Robert C Neely; John G Byrne; Igor Gosev; Lawrence H Cohn; Quratulain Javed; James D Rawn; Samuel Z Goldhaber; Gregory Piazza; Sary F Aranki; Prem S Shekar; Marzia Leacche
Journal:  Ann Thorac Surg       Date:  2015-07-10       Impact factor: 4.330

Review 6.  Extracorporeal membrane oxygenation in acute massive pulmonary embolism: a systematic review.

Authors:  H O Yusuff; V Zochios; A Vuylsteke
Journal:  Perfusion       Date:  2015-04-24       Impact factor: 1.972

7.  Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion.

Authors:  S Z Goldhaber; W D Haire; M L Feldstein; M Miller; R Toltzis; J L Smith; A M Taveira da Silva; P C Come; R T Lee; J A Parker
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

8.  Outcomes after surgical pulmonary embolectomy for acute submassive and massive pulmonary embolism: A single-center experience.

Authors:  Chetan Pasrija; Anthony Kronfli; Michael Rouse; Maxwell Raithel; Gregory J Bittle; Sheelagh Pousatis; Mehrdad Ghoreishi; James S Gammie; Bartley P Griffith; Pablo G Sanchez; Zachary N Kon
Journal:  J Thorac Cardiovasc Surg       Date:  2017-12-06       Impact factor: 5.209

9.  Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association.

Authors:  Jay Giri; Akhilesh K Sista; Ido Weinberg; Clive Kearon; Dharam J Kumbhani; Nimesh D Desai; Gregory Piazza; Mark T Gladwin; Saurav Chatterjee; Taisei Kobayashi; Christopher Kabrhel; Geoffrey D Barnes
Journal:  Circulation       Date:  2019-10-04       Impact factor: 29.690

Review 10.  Thrombosis: a major contributor to the global disease burden.

Authors: 
Journal:  J Thromb Haemost       Date:  2014-10       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.